Review began 06/17/2022 review ended 07/13/2022 published 07/17/2022 © copyright

HIGHLIGHTS

• who: Report et al. from the (UNIVERSITY) have published the paper: Review began 06/17/2022 Review ended 07/13/2022 Published 07/17/2022 © Copyright, in the Journal: (JOURNAL) of July/17,/2022
• what: The authors report the case of the lady who developed nail dystrophy as a side effect of nivolumab being taken for squamous cell carcinoma of the lip. Nivolumab is the primary focus of this paper because the case that the authors present used this treatment and had side effects from its use. The focus of the study severe inflammation of . . .
  

   

  

  If you want to have access to all the content you need to log in!

  Thanks :)

  Username or Email

  Password

  Remember me

  Lost your password?

  If you don't have an account, you can create one here.